Literature DB >> 31421857

The effect of diagnostic delay attributable to the healthcare system on the prognosis of colorectal cancer.

Jesús Daniel Fernández-de Castro1, Franco Baiocchi Ureta2, Raquel Fernández González3, Noel Pin Vieito2, Joaquín Cubiella Fernández4.   

Abstract

OBJECTIVES: To analyse the effect of a delay attributable to the healthcare system on a consecutive cohort of outpatients diagnosed with colorectal cancer in the healthcare area of Ourense (Spain). PATIENTS AND METHODS: We performed a retrospective cohort study that included patients diagnosed between 2009 and 2017. Delay attributable to the healthcare system was defined as the time between the first consultation with symptoms and the diagnostic confirmation. A logistic regression model was performed to evaluate the relationship between stage IV CRC and diagnostic delay. To analyse which variables were associated independently with overall mortality and mortality due to CRC we used a Cox regression model.
RESULTS: 575 patients were included (men 64.5%, age 71.9 ± 11.5 years), with a delay attributable to the healthcare system of 115 ± 153 days. None of the variables analysed were associated with tumour stage at diagnosis. With a mean follow-up of 30.6 ± 21 months, 121 patients died (79.3% due to CRC). The variables independently associated with CRC-related mortality were metastatic CRC (HR 50.65, 95% CI 12.28-209), age (HR 1.04, 95% CI 1.02-1.05) and colonoscopy requested from the Primary Healthcare level (HR 0.55, 95% CI 0.36-0.88).
CONCLUSIONS: Diagnostic delay attributable to the healthcare system is not related to the prognosis or stage of CRC. However, a direct referral to colonoscopy from the Primary Healthcare level reduces the risk of mortality in our patients.
Copyright © 2019 Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Atención Primaria; Colorectal cancer; Cáncer colorrectal; Demora diagnóstica; Diagnostic delay; Primary care; Prognosis; Pronóstico

Mesh:

Year:  2019        PMID: 31421857     DOI: 10.1016/j.gastrohep.2019.03.012

Source DB:  PubMed          Journal:  Gastroenterol Hepatol        ISSN: 0210-5705            Impact factor:   2.102


  6 in total

1.  Colorectal Cancer Prevalence and Survival in Cuenca (Spain).

Authors:  Laura Valiente González; Ricardo de Miguel Ibáñez; Francisco Escribano Sotos
Journal:  J Gastrointest Cancer       Date:  2022-01-13

2.  Data from a large Western centre exploring the impact of COVID-19 pandemic on endoscopy services and cancer diagnosis.

Authors:  Gaius Longcroft-Wheaton; Natalie Tolfree; Anmol Gangi; Richard Beable; Pradeep Bhandari
Journal:  Frontline Gastroenterol       Date:  2020-07-30

3.  Faecal Immunochemical Test Impact on Prognosis of Colorectal Cancer Detected in Symptomatic Patients.

Authors:  Jesús Daniel Fernández de Castro; Franco Baiocchi Ureta; Raquel Fernández González; Noel Pin Vieito; Joaquín Cubiella Fernández
Journal:  Diagnostics (Basel)       Date:  2022-04-17

Review 4.  Time to diagnosis and treatment in younger adults with colorectal cancer: A systematic review.

Authors:  Matthew Castelo; Colin Sue-Chue-Lam; Lawrence Paszat; Teruko Kishibe; Adena S Scheer; Bettina E Hansen; Nancy N Baxter
Journal:  PLoS One       Date:  2022-09-12       Impact factor: 3.752

5.  Influence of Diagnostic Delay on Survival Rates for Patients with Colorectal Cancer.

Authors:  María Padilla-Ruiz; María Morales-Suárez-Varela; Francisco Rivas-Ruiz; Julia Alcaide; Esperanza Varela-Moreno; Irene Zarcos-Pedrinaci; Teresa Téllez; Nerea Fernández-de Larrea-Baz; Marisa Baré; Amaia Bilbao; Cristina Sarasqueta; Urko Aguirre-Larracoechea; José María Quintana; Maximino Redondo
Journal:  Int J Environ Res Public Health       Date:  2022-03-18       Impact factor: 3.390

6.  Optimal diagnostic accuracy of quantitative faecal immunochemical test positivity thresholds for colorectal cancer detection in primary health care: A community-based cohort study.

Authors:  Noel Pin-Vieito; Laura García Nimo; Luis Bujanda; Begona Román Alonso; María Ángeles Gutierrez-Stampa; Vanessa Aguilar-Gama; Isabel Portillo; Joaquín Cubiella
Journal:  United European Gastroenterol J       Date:  2021-03-01       Impact factor: 4.623

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.